Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Travere Therapeutics Inc (NQ: TVTX )

6.000 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.000
Bid (Size) 5.820 (2)
Ask (Size) 6.720 (7)
Prev. Close 6.000
Today's Range 6.000 - 6.000
52wk Range 5.250 - 23.18
Shares Outstanding 60,717,176
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
From Travere Therapeutics, Inc.
Via GlobeNewswire
Where Travere Therapeutics Stands With Analysts
Via Benzinga

Performance

YTD
-70.96%
-70.96%
1 Month
-11.24%
-11.24%
3 Month
-54.27%
-54.27%
6 Month
-65.12%
-65.12%
1 Year
-68.44%
-68.44%

More News

Read More
Travere Therapeutics Reports Third Quarter 2023 Financial Results
From Travere Therapeutics, Inc.
Via GlobeNewswire
Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023
From Travere Therapeutics, Inc.
Via GlobeNewswire
Expert Ratings for Travere Therapeutics
Via Benzinga
Earnings Scheduled For November 7, 2023
Via Benzinga
Preview: Travere Therapeutics's Earnings
Via Benzinga
Travere Therapeutics to Report Third Quarter 2023 Financial Results
From Travere Therapeutics, Inc.
Via GlobeNewswire
Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
From Travere Therapeutics, Inc.
Via GlobeNewswire
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Travere Therapeutics, Inc.
Via GlobeNewswire
Travere Therapeutics, Inc. (NASDAQ:TVTX) Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties
Via SBWire
Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
From Travere Therapeutics, Inc.
Via GlobeNewswire
Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Shares of Travere Therapeutics Are Slumping Thursday
Via The Motley Fool
Why Former Highflier Travere Therapeutics Just Crashed 41% To A Decade-Low
Via Investor's Business Daily
Exposures Product Safety
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today?
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.